Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bariatric Surgery Effects on Glucose Metabolism
NCT02823665Phase 1Recruiting
- Sponsor
- UT Health San Antonio
- Start
- Jul 2015
- Primary completion
- Aug 2026
- Modality
- Peptides, Classical Binding Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, single-blind trial in hypoglycemia comparing Exendin-(9-39) with Atropine (2 arms). Primary endpoint: Insulin levels at 7 hours. Started Jul 2015; status: recruiting.
02
Drugs
exendin 9-39atropine
03
Conditions
hypoglycemia
Beyond the preview
Go deeper on NCT02823665.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02823665.